| NOTCH1 mutations in CLL associated with trisomy 12 V Balatti, A Bottoni, A Palamarchuk, H Alder, LZ Rassenti, TJ Kipps, ... Blood, The Journal of the American Society of Hematology 119 (2), 329-331, 2012 | 276 | 2012 |
| tsRNA signatures in cancer V Balatti, G Nigita, D Veneziano, A Drusco, GS Stein, TL Messier, ... Proceedings of the National Academy of Sciences 114 (30), 8071-8076, 2017 | 228 | 2017 |
| Karyotype-specific microRNA signature in chronic lymphocytic leukemia R Visone, LZ Rassenti, A Veronese, C Taccioli, S Costinean, BD Aguda, ... Blood, The Journal of the American Society of Hematology 114 (18), 3872-3879, 2009 | 226 | 2009 |
| Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer Y Pekarsky, V Balatti, A Palamarchuk, L Rizzotto, D Veneziano, G Nigita, ... Proceedings of the National Academy of Sciences 113 (18), 5071-5076, 2016 | 214 | 2016 |
| BCL2 and miR-15/16: from gene discovery to treatment Y Pekarsky, V Balatti, CM Croce Cell Death & Differentiation 25 (1), 21-26, 2018 | 191 | 2018 |
| miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia R Visone, A Veronese, LZ Rassenti, V Balatti, DK Pearl, M Acunzo, ... Blood, The Journal of the American Society of Hematology 118 (11), 3072-3079, 2011 | 164 | 2011 |
| In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation F Pichiorri, D Palmieri, L De Luca, J Consiglio, J You, A Rocci, T Talabere, ... Journal of Experimental Medicine 210 (5), 951-968, 2013 | 157 | 2013 |
| Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2 M Acunzo, G Romano, D Palmieri, A Laganá, M Garofalo, V Balatti, ... Proceedings of the National Academy of Sciences 110 (21), 8573-8578, 2013 | 130 | 2013 |
| miR-15b/16-2 deletion promotes B-cell malignancies F Lovat, M Fassan, P Gasparini, L Rizzotto, L Cascione, M Pizzi, ... Proceedings of the National Academy of Sciences 112 (37), 11636-11641, 2015 | 120 | 2015 |
| Role of microRNA in chronic lymphocytic leukemia onset and progression V Balatti, Y Pekarky, CM Croce Journal of hematology & oncology 8, 1-6, 2015 | 103 | 2015 |
| Simian virus 40 in humans F Martini, A Corallini, V Balatti, S Sabbioni, C Pancaldi, M Tognon Infectious agents and cancer 2, 1-12, 2007 | 102 | 2007 |
| B-cell malignancies in microRNA Eμ-miR-17∼ 92 transgenic mice SK Sandhu, M Fassan, S Volinia, F Lovat, V Balatti, Y Pekarsky, ... Proceedings of the National Academy of Sciences 110 (45), 18208-18213, 2013 | 99 | 2013 |
| MicroRNAs dysregulation in human malignant pleural mesothelioma V Balatti, S Maniero, M Ferracin, A Veronese, M Negrini, G Ferrocci, ... Journal of thoracic oncology 6 (5), 844-851, 2011 | 98 | 2011 |
| Role of the tRNA-derived small RNAs in cancer: new potential biomarkers and target for therapy V Balatti, Y Pekarsky, CM Croce Advances in cancer research 135, 173-187, 2017 | 82 | 2017 |
| TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia V Balatti, L Rizzotto, C Miller, A Palamarchuk, P Fadda, R Pandolfo, ... Proceedings of the National Academy of Sciences 112 (7), 2169-2174, 2015 | 79 | 2015 |
| Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL) A Palamarchuk, PS Yan, N Zanesi, L Wang, B Rodrigues, M Murphy, ... Proceedings of the National Academy of Sciences 109 (7), 2555-2560, 2012 | 73 | 2012 |
| Mutated β-catenin evades a microRNA-dependent regulatory loop A Veronese, R Visone, J Consiglio, M Acunzo, L Lupini, T Kim, M Ferracin, ... Proceedings of the National Academy of Sciences 108 (12), 4840-4845, 2011 | 70 | 2011 |
| MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia R Visone, A Veronese, V Balatti, CM Croce Oncotarget 3 (2), 195, 2012 | 60 | 2012 |
| Identification of tRNA‐derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer NH Farina, S Scalia, CE Adams, D Hong, AJ Fritz, TL Messier, V Balatti, ... Journal of cellular physiology 235 (6), 5318-5327, 2020 | 59 | 2020 |
| MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia LZ Rassenti, V Balatti, EM Ghia, A Palamarchuk, L Tomasello, P Fadda, ... Proceedings of the National Academy of Sciences 114 (40), 10731-10736, 2017 | 56 | 2017 |
Yuri PekarskyThe Ohio State University在 osumc.edu 的电子邮件经过验证
